| 世界卫生组织新的药物战略及启示 |
| |
| 引用本文： | 李轩,刘琰,孙利华.世界卫生组织新的药物战略及启示[J].中国药房,2008,19(4):254-256. |
| |
| 作者姓名： | 李轩 刘琰 孙利华 |
| |
| 作者单位： | 1. 沈阳药科大学工商管理学院,沈阳市,110016
2. 东北制药总厂,沈阳市,110026 |
| |
| 摘 要： | 目的:为我国药物政策制定、完善及相关研究提供参考。方法:介绍世界卫生组织新的药物战略内容、定期的监测与评价内容及战略的合作执行情况等,引发启示。结果与结论:世界卫生组织新的药物战略是其基本药物可及性目标实现的基本保障,而我国基本药物的可及性同样需要国家药物政策的大力支持及政府和社会可持续的作为。
|
| 关 键 词： | 世界卫生组织 新的药物战略 基本药物 可及性 |
| 文章编号： | 1001-0408（2008）04-0254-03 |
| 收稿时间： | 2007-06-15 |
| 修稿时间： | 2007-09-20 |
WHO New Drugs Strategy and Its Implication for China |
| |
| LI Xuan,LIU Yan,SUN Li-hua.WHO New Drugs Strategy and Its Implication for China[J].China Pharmacy,2008,19(4):254-256. |
| |
| Authors: | LI Xuan LIU Yan SUN Li-hua |
| |
| Institution: | LI Xuan, SUN Li-hua,LIU Yan(College of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China;Northeast General Pharmaceutical Factory, Shenyang 110026, China) |
| |
| Abstract: | OBJECTIVE： To provide references for the establishment and evolvement of national drugs policy as well as its related research. METHODS： The contents of the new drug strategy and the contents subjected to regular monitoring and evaluation as well the cooperative implementation of the strategy etc were introduced, and its implication for China was analyzed. RESULTS ＆ CONCLUSIONS： The accessibility to essential drugs can be guaranteed with the help of WHO＇ s new drugs strategy, likewise, the accessibility to essential drugs in China can＇t be realized without the great support of the national drugs policy and the sustainable efforts of both the government and the society. |
| |
| Keywords: | WHO New drugs strategy Essential drugs Accessibility |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
